| Autor: |
Villeneuve, Sarah-Christine, Houot, Marion, Cacciamani, Federica, Verrijp, Merike, Dubois, Bruno, Sikkes, Sietske, Epelbaum, Stéphane, Bakardjian, Hovagim, Benali, Habib, Bertin, Hugo, LaurieBoukadida, Joel Bonheur, Boukerrou, Nadia, Cavedo, Enrica, Chiesa, Patrizia, Colliot, Olivier, Dubois, Bruno, Dubois, Marion, Epelbaum, Stéphane, Gagliardi, Geoffroy, Genthon, Remy, Habert, Marie-Odile, Hampel, Harald, Houot, Marion, Kas, Aurélie, Lamari, Foudil, Levy, Marcel, Lista, Simone, Metzinger, Christiane, Mochel, Fanny, Nyasse, Francis, Poisson, Catherine, Potier, Marie-Claude, Revillon, Marie, Santos, Antonio, Andrade, Katia Santos, Sole, Marine, Surtee, Mohmed, Thiebaud de Schotten, Michel, Vergallo, Andrea, Younsi, Nadjia |
| Zdroj: |
Alzheimer's & Dementia: Translational Research & Clinical Interventions; January 2019, Vol. 5 Issue: 1 p553-562, 10p |
| Abstrakt: |
Trials in Alzheimer's disease (AD) now include participants at the earliest stages to prevent further decline. However, the lack of tools sensitive to subtle functional changes in early-stage AD hinders the development of new therapies as it is difficult to prove their clinical relevance. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Plný text 